Both in Pharmaceuticals
Mustang Bio vs Jupiter Neurosciences
Over the past year MBIO returned −72.6% and JUNS returned −98.0%; their daily moves had a correlation of -0.07.
MBIO −72.6% JUNS −98.0%Growth of $1, one year, split-adjusted
| Metric | MBIO | JUNS |
|---|---|---|
| Price | $0.4001 | $2.05 |
| Market cap | $3.0M | $2.7M |
| Today | +1.94% | −13.50% |
| 1 month | −14.4% | −18.0% |
| 6 months | −47.0% | −93.0% |
| Year to date | −59.2% | −97.3% |
| 1 year | −72.8% | −98.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 86.9% |
| Net margin | — | −9380.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 41.8× |
| Net cash | $15.2M | -$6.6K |
| Dividend yield | — | — |
| Volatility (60d) | 50.3% | 903.4% |
| Short % of float | 1.0% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).